Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZFP3 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | DCHS1 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
mRNA | ZNF766 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | GRM2 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | DAGLA | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | MAZ | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | S100A6 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
mRNA | LDHA | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | ZKSCAN2 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | CINP | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |